These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4386133)

  • 21. [Therapeutic use of beta-adrenergic blocking agents].
    Renner C; Rouffy J
    Presse Med (1893); 1967 Jul; 75(32):1651-3. PubMed ID: 6027505
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hemodynamic effects of a new inhibitor of adrenergic beta receptors (LB 46)].
    Lejwi G; Fabiato A; Gut JP; Gourgon R
    Arch Mal Coeur Vaiss; 1971 Nov; 64(11):1654-68. PubMed ID: 4402388
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of sympatholytics in internal medicine].
    Med Klin; 1970 May; 65(19):930-1. PubMed ID: 4399346
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypotensive, antiarrhythmic and chronotropic action of Trasicor (Ciba 39089--Ba).
    Waal HJ
    N Z Med J; 1968 Mar; 67(429):291-5. PubMed ID: 5239619
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of propranolol in coronary insufficiency and in some cardiac arrhythmias].
    Zavala Jurado A; Gonzalez Martin A; De Feuillade ND; Liñan JM
    Prensa Med Argent; 1968 Aug; 55(26):1271-8. PubMed ID: 4974565
    [No Abstract]   [Full Text] [Related]  

  • 26. Contribution to the clinical evaluation of beta-adrenergic blocking drugs: 1-p-nitrophenyl-2-isopropylaminoethanol (INPEA) as an antagonist of catecholamines in normal persons and in coronary disease patients.
    Piva M; Ongari R
    Arzneimittelforschung; 1968 Feb; 18(2):179-88. PubMed ID: 5695376
    [No Abstract]   [Full Text] [Related]  

  • 27. [The use of an adrenergic beta-receptor blocking agent in coronary insufficiency and heart rhythm disorders].
    Doshchitsyn VL
    Kardiologiia; 1966; 6(5):65-9. PubMed ID: 6000275
    [No Abstract]   [Full Text] [Related]  

  • 28. [Data on the effects of butydrine in patients with coronary insufficiency].
    De Maestri C; Rinaldi AR
    Minerva Cardioangiol; 1969 Feb; 17(2):142-50. PubMed ID: 5777638
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of angina pectoris and arrthymias with a beta receptor blockader].
    Willems D; Frisch P; Klepzig H
    Z Kreislaufforsch; 1971 Apr; 60(4):309-18. PubMed ID: 4397060
    [No Abstract]   [Full Text] [Related]  

  • 30. [Protective effect of a beta-blockador on clinico-electrocardiographic manifestations in the coronary insufficiency apparent during Master's test: description of a clinical case].
    Conti G; Piemontese M; Savarese A; Valva M
    Clin Ter; 1969 Apr; 49(2):181-7. PubMed ID: 4401859
    [No Abstract]   [Full Text] [Related]  

  • 31. [Blocking of adrenergic beta-receptors. A new therapeutic principle].
    Kusus T; Schnelle K; Lydtin H
    Ther Ggw; 1968 Mar; 107(3):280 passim. PubMed ID: 4388462
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical experience with the association of a beta-blocking agent and pentaerythrite].
    Barbi G; Tallone G
    Minerva Cardioangiol; 1969 Feb; 17(2):139-41. PubMed ID: 5777637
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental and clinical experience with the beta receptor blockader Obsidan].
    Krosch H; Rikirsch P; Schäbitz J; Teichmann W
    Z Gesamte Inn Med; 1969 Oct; 24(19):655-9. PubMed ID: 4188437
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of beta adrenergic receptor blockaders studied with propranolol on the ventricular repolarizzation in patients with hypertensive heart disease and chronic coronary insufficiency].
    Zani D; Melara D
    Cardiol Prat; 1969 Jun; 20(3):211-27. PubMed ID: 5407605
    [No Abstract]   [Full Text] [Related]  

  • 35. [On some special clinical indications of beta-blocking agents].
    Pretolani E
    Cardiol Prat; 1969 Apr; 20(2):115-24. PubMed ID: 5794979
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of a new anti-arrhythmic drug, bunaftine, on intra-atrial, atrio-ventricular and intraventricular conduction of the stimulus].
    Grazi S; Romano S; Bonazzi O; Pozzoni L; Cavoretto D; Gardumi M; Sardella F
    Cardiol Prat; 1974; 25(3):213-8. PubMed ID: 4434374
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the effect of beta-adrenergic receptor blocking agents in thyroitoxic cardiopathies in the aged. (Statistical study)].
    Pasoli CA; Forte PL; Luzi-Crivellini A; Pasoli A; Girelli Bruni E; Bellini P
    Fracastoro; 1970; 63(1):18-32. PubMed ID: 4394523
    [No Abstract]   [Full Text] [Related]  

  • 38. [Adrenergic beta-receptor blocking agents in the treatment of cardiothyreosis (arrhythmias, angina pectoris)].
    Popovici D
    Stud Cercet Endocrinol; 1969; 20(1):63-74. PubMed ID: 5343647
    [No Abstract]   [Full Text] [Related]  

  • 39. [Beta-blocking drugs in cardiac therapy].
    Pretolani E
    G Clin Med; 1968 Feb; 49(2):221-8. PubMed ID: 4392710
    [No Abstract]   [Full Text] [Related]  

  • 40. The treatment of functional heart disorders with beta-adrenergic blocking agents.
    Imhof P; Brunner H
    Postgrad Med J; 1970 Nov; ():Suppl:96-9. PubMed ID: 4395467
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.